Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Penile Neoplasms × cemiplimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 20 Squamous Cell Carcinoma of Head and Neck 7 Lung Neoplasms 7 Neoplasms 6 Melanoma 6 Carcinoma, Squamous Cell 5 Skin Neoplasms 4 Carcinoma, Renal Cell 4 Urinary Bladder Neoplasms 3 Head and Neck Neoplasms 3 Colonic Neoplasms 3 Carcinoma 3 Breast Neoplasms 3 Adenocarcinoma 3 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Carcinoma, Merkel Cell 2 Carcinoma, Hepatocellular 2 Carcinoma, Basal Cell 2 Adrenocortical Carcinoma 2 Vulvar Neoplasms 1 Vaccinia 1 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 4 Nivolumab 4 Cisplatin 3 avelumab 2 Paclitaxel 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 Ifosfamide 2 vinflunine 1 toripalimab 1 niraparib 1 nimotuzumab 1 fludarabine phosphate 1 fludarabine 1 enfortumab vedotin 1 dostarlimab 1 dacomitinib 1 cemiplimab 1 cabozantinib 1 cabazitaxel 1 aldesleukin 1 Vorinostat 1 Specimen Handling 1 Ritonavir 1 Radiotherapy 1 Neoadjuvant Therapy 1 Isotretinoin 1 Irinotecan 1 Interferon-alpha 1 Indinavir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101822 2025-08-03

BRAVA PENILE

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Penile Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡